Prevalence of anti-ulcer drug use in a Chinese cohort

Table 2 Recipients of anti-ulcer drugs by main ingredient from 1997 to 2001 (number of new users in parentheses)

ATCa coding	Group/ingredient name	1997	1998	1999	2000	2001	1997-2001
A02BA H2 RA
	01 Cimetidine	11538	15793 (11340)	22905 (14525)	22356(10564)	24305 (9667)	57634
	02 Ranitidine	1588	1852 (1482)	2262 (1757)	2283 (1611)	2579 (1802)	8240
	03 Famotidine	974	1143 (953)	1401 (1113)	1526 (1216)	1669 (1232)	5488
	04 Nizatidine	187	255 (221)	295 (236)	199 (157)	137 (108)	909
	06 Roxatidine	89	98 (82)	87 (76)	83 (67)	97 (80)	394
A02BB Prostaglandins
	01 Misoprostol	128	145 (129)	156 (135)	150 (112)	88 (68)	572
A02BC PPIS
	01 Omeprazole	709	913 (807)	1168 (990)	1150 (917)	1445 (1156)	4579
	02 Pantoprazole	-	1(1)	84 (84)	147 (133)	273 (255)	473
	03 Lansoprazole	151	391 (365)	531 (459)	647 (537)	785 (643)	2155
	04 Rabeprazole	-	-	-	-	31 (31)	31
A02BX Other drugs
	01 Carbenoxolone	287	260 (219)	337 (271)	155 (105)	199 (164)	1046
	02 Sucralfate	3463	3192 (2510)	3107 (2301)	2390 (1506)	2173 (1390)	11170
	03 Pirenzepine	1177	1197 (937)	1181 (857)	731 (454)	625 (351)	3776
	05 Bismuth subcitrate	329	299 (266)	271 (223)	173 (141)	142 (111)	1070
	06 Proglumide	113	61 (53)	36 (34)	3 (3)	8 (5)	208
	07 Gefarnate	248	295 (270)	416 (363)	326 (265)	203 (161)	130 7
	- Cetraxate	356	101 (81)	72 (59)	48 (40)	41 (37)	57 3
	- Urogastrone	192	46 (34)	42 (32)	14 (12)	6 (5)	275
Total		17415	21352 (14423)	28602(16611)	27178(11660)	2918123(10622)	70729

^aATC = Anatomical therapeutic chemical classification system.